NFKB1 and cancer: The inhibition of proteasome became an extensively studied strategy in cancer treatment due to the importance of ubiquitin–proteasome system in the promotion of cell cycle progression and activation of NF-κB signaling pathway as well as removal of tumor suppressor protein p53 [14].